- Conditions
- Asthma
- Interventions
- ADC3680, Placebo, montelukast
- Drug
- Lead sponsor
- Pulmagen Therapeutics
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 248 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 35
- States / cities
- Birmingham, Alabama • Huntington Beach, California • Riverside, California + 32 more
Source: ClinicalTrials.gov public record
Updated Oct 5, 2017 · Synced May 22, 2026, 5:46 AM EDT